Chloride ion
- Generic Name
- Chloride ion
- Drug Type
- Small Molecule
- Chemical Formula
- Cl
- CAS Number
- 16887-00-6
- Unique Ingredient Identifier
- Q32ZN48698
Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery
Phase 3
Completed
- Conditions
- Participants With Acute Moderate to Severe Pain Following Abdominal Surgery
- Interventions
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Yangtze River Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 224
- Registration Number
- NCT06904248
- Locations
- 🇨🇳
Cangzhou People's Hospital, Cangzhou, China
🇨🇳The Third Xiangya Hospital Of Central South University, Changsha, China
🇨🇳Heping Hospital Affiliated To Changzhi Medical College, Changzhi, China
Hydromorphone Hydrochloride Epidural Preemptive Analgesia for Postoperative Pain After Cesarean Section
Phase 4
Not yet recruiting
- Conditions
- Post-surgical Pain
- Interventions
- Drug: Hydromorphone hydrochloride low doseDrug: Hydromorphone hydrochloride high dose
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Liquan Liang
- Target Recruit Count
- 105
- Registration Number
- NCT06823180
A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects
Phase 1
Recruiting
- Conditions
- Healthy Participants
- Interventions
- Drug: BPR-30221616 Injection
- First Posted Date
- 2025-01-06
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Chengdu Brilliant Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06760455
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years
Phase 1
- Conditions
- Pneumococcal Infectious Disease
- Interventions
- Biological: PCV24 formulation 1Biological: PCV24 formulation 2
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Shanghai Reinovax Biologics Co.,LTD
- Target Recruit Count
- 230
- Registration Number
- NCT06675032
- Locations
- 🇨🇳
Luzhou District Center for Disease Control and Prevention, Changzhi City, Changzhi, Shanxi, China
A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 8
- Registration Number
- NCT06658626
- Locations
- 🇺🇸
Labcorp Clinical Research Unit Inc. (Site 0001), Madison, Wisconsin, United States
Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery
Phase 1
Recruiting
- Conditions
- DexmedetomidineFascia Iliaca Block
- Interventions
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2024-09-26
- Lead Sponsor
- Qianfoshan Hospital
- Target Recruit Count
- 207
- Registration Number
- NCT06614010
- Locations
- 🇨🇳
Qianfoshan Hospital, Jinan, Shandong, China
Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
Phase 2
Completed
- Conditions
- Acute Bronchiolitis
- Interventions
- Other: Standard care
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Can Tho University of Medicine and Pharmacy
- Target Recruit Count
- 140
- Registration Number
- NCT06558461
- Locations
- 🇻🇳
Can Tho Children's Hospital, Can Tho, Vietnam
Evaluation of the Benefit and Safety of Localized Tissue Hydration in the Management of Chronic Low Back Pain
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Target Recruit Count
- 29
- Registration Number
- NCT06471998
- Locations
- 🇫🇷
Hôpital Privé Clairval, Marseille, France
Erector Spinae Plane Block for Cervical Spine Surgery
Phase 4
Recruiting
- Conditions
- Spine FusionSpinal DiseaseSpine Disease
- Interventions
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Poznan University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT06393530
- Locations
- 🇵🇱
Poznan University of Medical Sciences, Poznan, Poznań, Poland
Interpectoral-pectoserratus Plane Block for Minimally Invasive Aortic Valve Replacement Via Right Anterior Minithoracotomy
Phase 4
Not yet recruiting
- Conditions
- Analgesic Effect
- Interventions
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Algemeen Ziekenhuis Maria Middelares
- Target Recruit Count
- 144
- Registration Number
- NCT06369870
- Locations
- 🇧🇪
AZ Maria Middelares, Ghent, East-Flanders, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath